Quest Diagnostics (DGX) Tops Q4 EPS by 4c; Guides Above the Street

Go back to Quest Diagnostics (DGX) Tops Q4 EPS by 4c; Guides Above the Street

Wells Fargo Downgrades Quest Diagnostics (DGX) to Underperform

January 30, 2015 7:08 AM EST

Wells Fargo downgraded Quest Diagnostics (NYSE: DGX) from Market Perform to Underperform with a price target of $60-$65. Analyst Gary Lieberman said thinks investors should view the expense associated with the Invigorate savings initiative as ongoing.

For an analyst ratings summary and... More

Quest Diagnostics (DGX) Raises Quarterly Dividend 15.2% to $0.38; 2.2% Yield

January 29, 2015 7:54 AM EST

Quest Diagnostics (NYSE: DGX) declared a quarterly dividend of $0.38 per share, or $1.52 annualized. This is a 15.2% increase from the prior dividend of $0.33.

The dividend will be payable on April 22, 2015, to stockholders of record on April 8, 2015, with an ex-dividend date of April 6,... More